| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $10.3M | -83.7% |
| R&D Expense | $88.8M | -9.8% |
| SG&A Expense | $36.6M | +70.5% |
| Operating Income | -$115.2M | -102.7% |
| Pre-tax Income | -$128.7M | -122.7% |
| Income Tax | $24K | — |
| Net Income | -$128.7M | -122.7% |
| EPS (Basic) | -$4.57 | -116.6% |
| EPS (Diluted) | -$4.57 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $71.3M | -85.6% |
| Accounts Receivable | $1.4M | +62.0% |
| Current Assets | $447.2M | -19.3% |
| Total Assets | $610.4M | -5.1% |
| Current Liabilities | $26.1M | +61.8% |
| Stockholders' Equity | $262.1M | -26.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$73.6M | -60.3% |
| Capital Expenditures | $358K | -73.8% |
| Investing Cash Flow | -$394.8M | -1116.7% |
| Financing Cash Flow | $44.0M | -82.6% |
| Free Cash Flow | -$74.0M | -56.4% |
| -116.6% |